Praxis Precision Medicines (PRAX) News Today $45.54 -0.45 (-0.98%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$45.52 -0.02 (-0.05%) As of 08/29/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRAX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Tri Locum Partners LP Has $3.17 Million Stock Holdings in Praxis Precision Medicines, Inc. $PRAXAugust 30 at 8:04 AM | marketbeat.comPrice T Rowe Associates Inc. MD Decreases Stock Position in Praxis Precision Medicines, Inc. $PRAXAugust 30 at 4:22 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 29 at 10:05 AM | globenewswire.comPraxis Precision Medicines to Participate in Upcoming Fireside ChatAugust 29 at 8:00 AM | globenewswire.comPraxis Precision Medicines, Inc. $PRAX Stock Holdings Increased by Walleye Capital LLCAugust 29 at 5:20 AM | marketbeat.comVanguard Group Inc. Purchases 23,381 Shares of Praxis Precision Medicines, Inc. $PRAXAugust 29 at 3:13 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 27 at 10:00 AM | prnewswire.comCandriam S.C.A. Lowers Holdings in Praxis Precision Medicines, Inc. $PRAXAugust 26, 2025 | marketbeat.comAlgert Global LLC Invests $814,000 in Praxis Precision Medicines, Inc. $PRAXAugust 26, 2025 | marketbeat.comPraxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy PipelineAugust 25, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 25, 2025 | globenewswire.comPRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Praxis Precision Medicines, Inc. on Behalf of Praxis Stockholders and Encourages Investors to Contact the FirmAugust 23, 2025 | globenewswire.comAberdeen Group plc Increases Stock Position in Praxis Precision Medicines, Inc. $PRAXAugust 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 22, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 21, 2025 | globenewswire.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $85.88 Consensus PT from AnalystsAugust 20, 2025 | americanbankingnews.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 17, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 16, 2025 | prnewswire.comProtect Your Investment: Contact Levi & Korsinsky About the Praxis Precision Medicines, Inc. (PRAX) InvestigationAugust 14, 2025 | theglobeandmail.comPRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. ...August 14, 2025 | gurufocus.comPRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law FirmAugust 14, 2025 | prnewswire.comPRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law FirmAugust 13, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 11, 2025 | prnewswire.comChardan Capital Brokers Lower Earnings Estimates for PRAXAugust 11, 2025 | marketbeat.comXTX Topco Ltd Purchases Shares of 10,043 Praxis Precision Medicines, Inc. (NASDAQ:PRAX)August 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 9, 2025 | globenewswire.comPraxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of VormatrigineAugust 8, 2025 | theglobeandmail.comResearch Analysts Issue Forecasts for PRAX Q3 EarningsAugust 8, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for PRAX FY2029 Earnings?August 7, 2025 | marketbeat.comWedbush Issues Negative Estimate for PRAX EarningsAugust 7, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 6, 2025 | prnewswire.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Praxis Precision Medicines (PRAX) and Pfizer (PFE)August 6, 2025 | theglobeandmail.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 8.1% - Here's WhyAugust 6, 2025 | marketbeat.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 6, 2025 | gurufocus.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 6, 2025 | globenewswire.comPraxis Precision Medicines (PRAX) Projected to Post Earnings on TuesdayAugust 6, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for Praxis Precision Medicines (NASDAQ:PRAX) StockAugust 6, 2025 | marketbeat.comPraxis Precision Medicines First Half 2025 Earnings: US$6.60 loss per share (vs US$4.58 loss in 1H 2024)August 5, 2025 | finance.yahoo.comPraxis Precision Medicines to Participate in Upcoming Fireside ChatAugust 5, 2025 | globenewswire.comPraxis Precision Medicines, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 5, 2025 | globenewswire.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down - Time to Sell?August 5, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Posts Earnings Results, Beats Expectations By $0.09 EPSAugust 5, 2025 | marketbeat.comPraxis Precision Medicines to Participate in Upcoming Fireside ChatAugust 4, 2025 | globenewswire.comPraxis Precision Shares Climb on Seizure Treatment Trial ResultsAugust 4, 2025 | marketwatch.comPraxis Precision Medicines stock soars after positive epilepsy drug resultsAugust 4, 2025 | investing.comPraxis Precision jumps after mid-stage trial data for anti-seizure therapyAugust 4, 2025 | msn.comPraxis' Epilepsy Treatment Shows Promise With Decreased SeizuresAugust 4, 2025 | benzinga.comPraxis Precision Medicines Shares Surge on Promising Epilepsy Drug DataAugust 4, 2025 | msn.com Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRAX Media Mentions By Week PRAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAX News Sentiment▼0.951.05▲Average Medical News Sentiment PRAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAX Articles This Week▼126▲PRAX Articles Average Week Get the Latest News and Ratings for PRAX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PTC Therapeutics News Today Lantheus News Today Arcellx News Today Akero Therapeutics News Today Zai Lab News Today Mirum Pharmaceuticals News Today MoonLake Immunotherapeutics News Today Protagonist Therapeutics News Today Apellis Pharmaceuticals News Today Jyong Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
